With the threat of more restricted pharmacy networks on the horizon, do you anticipate more deals like Walgreens-USA Drug?

This is only one driver. The final wave of drug channel consolidation is underway as pressures build on the few viable family run chains left in the business, the owners age and the synergies involved in purchasing these chains by the power players becomes ever more compelling. Sadly, the age of entrepreneurial family owned small chains is passing and if the price is attractive enough most will take the money and call it a day. Jay Forbes The Forbes Connection LLC